Search research articles
Contact Us
Filters
Showing results (51-60 of 693) with videos related to
Page
of 70
Sort By:
Lancet (London, England)
|
October 24, 2006
Oral renin inhibitors
Jan A Staessen, Yan Li, Tom Richart
Journal of Hypertension
|
December 5, 2006
Meta-analysis of blood pressure and the CYP11B2 polymorphism highlights the need for better designed studies
Jan A Staessen, Yan Li, Lutgarde Thijs
Hypertension (Dallas, Tex. : 1979)
|
March 29, 2006
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories
Paolo Verdecchia, Fabio Angeli, Jan A Staessen
Lancet (London, England)
|
October 8, 2013
Retraction of the Jikei Heart Study: misquotation of a Comment
Kei Asayama, Azusa Hara, Jan A Staessen
BMJ (Clinical Research Ed.)
|
May 16, 2008
Reducing blood pressure in people of different ages
Jan A Staessen, Tom Richart, Paolo Verdecchia
The Lancet. Neurology
|
November 12, 2010
Methodological issues in the assessment of cognitive decline in ONTARGET and TRANSCEND
Augustine N Odili, Tom Richart, Jan A Staessen
European Heart Journal
|
August 6, 2010
Of fads, fashion, surrogate endpoints and dual RAS blockade
Franz H Messerli, Jan A Staessen, Faiez Zannad
Clinical Medicine & Research
|
June 18, 2005
Self-measurement of blood pressure at home in the management of hypertension
Hilde Celis, Elly Den Hond, Jan A Staessen
Circulation
|
September 29, 2005
Letter regarding article by Sega et al, "Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population"
Eamon Dolan, Eoin T O'Brien, Jan A Staessen
Hypertension (Dallas, Tex. : 1979)
|
March 21, 2012
Does pseudoresistant hypertension attributed to white-coat effect define subjects with "treated normalized hypertension?"
Stanley S Franklin, Lutgarde Thijs, Jan A Staessen
Page
of 70
Search research articles
Search
Showing results (51-60 of 693) with videos related to
Sort By:
Page
of 70
Lancet (London, England)
|
October 24, 2006
Oral renin inhibitors
Jan A Staessen, Yan Li, Tom Richart
Journal of Hypertension
|
December 5, 2006
Meta-analysis of blood pressure and the CYP11B2 polymorphism highlights the need for better designed studies
Jan A Staessen, Yan Li, Lutgarde Thijs
Hypertension (Dallas, Tex. : 1979)
|
March 29, 2006
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories
Paolo Verdecchia, Fabio Angeli, Jan A Staessen
Lancet (London, England)
|
October 8, 2013
Retraction of the Jikei Heart Study: misquotation of a Comment
Kei Asayama, Azusa Hara, Jan A Staessen
BMJ (Clinical Research Ed.)
|
May 16, 2008
Reducing blood pressure in people of different ages
Jan A Staessen, Tom Richart, Paolo Verdecchia
The Lancet. Neurology
|
November 12, 2010
Methodological issues in the assessment of cognitive decline in ONTARGET and TRANSCEND
Augustine N Odili, Tom Richart, Jan A Staessen
European Heart Journal
|
August 6, 2010
Of fads, fashion, surrogate endpoints and dual RAS blockade
Franz H Messerli, Jan A Staessen, Faiez Zannad
Clinical Medicine & Research
|
June 18, 2005
Self-measurement of blood pressure at home in the management of hypertension
Hilde Celis, Elly Den Hond, Jan A Staessen
Circulation
|
September 29, 2005
Letter regarding article by Sega et al, "Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population"
Eamon Dolan, Eoin T O'Brien, Jan A Staessen
Hypertension (Dallas, Tex. : 1979)
|
March 21, 2012
Does pseudoresistant hypertension attributed to white-coat effect define subjects with "treated normalized hypertension?"
Stanley S Franklin, Lutgarde Thijs, Jan A Staessen
Page
of 70